Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Sold by Summit Place Financial Advisors LLC

Summit Place Financial Advisors LLC lessened its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 4.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 37,910 shares of the real estate investment trust’s stock after selling 1,584 shares during the period. Summit Place Financial Advisors LLC’s holdings in Omega Healthcare Investors were worth $1,543,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Park Avenue Securities LLC raised its stake in shares of Omega Healthcare Investors by 5.7% in the 1st quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after purchasing an additional 544 shares in the last quarter. Hennion & Walsh Asset Management Inc. lifted its holdings in Omega Healthcare Investors by 96.7% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock worth $690,000 after buying an additional 10,714 shares during the last quarter. Cornerstone Wealth Group LLC bought a new position in Omega Healthcare Investors during the 1st quarter worth approximately $231,000. Allspring Global Investments Holdings LLC grew its position in shares of Omega Healthcare Investors by 93.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,803 shares of the real estate investment trust’s stock worth $152,000 after acquiring an additional 2,324 shares in the last quarter. Finally, State of Michigan Retirement System increased its holdings in shares of Omega Healthcare Investors by 2.6% in the 1st quarter. State of Michigan Retirement System now owns 60,263 shares of the real estate investment trust’s stock valued at $1,909,000 after acquiring an additional 1,500 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $41.76 on Monday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $41.93. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. The firm has a market capitalization of $10.32 billion, a price-to-earnings ratio of 37.43, a price-to-earnings-growth ratio of 1.33 and a beta of 1.00. The business has a 50 day simple moving average of $40.10 and a 200 day simple moving average of $35.64.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The business had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same period in the previous year, the company posted $0.74 EPS. The company’s revenue for the quarter was up 17.5% compared to the same quarter last year. On average, equities research analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Insider Buying and Selling at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on OHI shares. Scotiabank raised their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research note on Monday, August 26th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Finally, BMO Capital Markets upped their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a report on Monday, October 7th. Eight equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $37.80.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.